A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): The European PH1 transplant registry experience 1984-2004

American Journal of Nephrology

Volumn 25, Issue 3, 2005, Pages 282-289

  Jamieson, Neville V ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Combined liver kidney transplantation; Primary hyperoxaluria

Indexed keywords

ALANINE GLYOXYLATE AMINOTRANSFERASE; OXALIC ACID;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; CONFERENCE PAPER; DIALYSIS; ENZYME ACTIVITY; ENZYME DEFECT; FOLLOW UP; GRAFT SURVIVAL; HUMAN; HYPERGLYCOLICACIDURIA; HYPEROXALEMIA; HYPEROXALURIA; KIDNEY CALCIFICATION; KIDNEY FAILURE; KIDNEY GRAFT; LIVER BIOPSY; LIVER GRAFT; OBSTRUCTIVE UROPATHY; OXALOSIS 1; PATIENT INFORMATION; PRIORITY JOURNAL; REGISTER; SURGICAL PATIENT; SURVIVAL RATE;

CHILD; CHILD, PRESCHOOL; CREATININE; EUROPE; GRAFT SURVIVAL; HUMANS; HYPEROXALURIA, PRIMARY; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; OXALATES; POSTOPERATIVE PERIOD; REGISTRIES; RENAL DIALYSIS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 23944502312     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086359     Document Type: Conference Paper

References (44)

1. Danpure CJ, et al: Primary hyperoxaluria type 1: genotypic and phenotypic heterogeneity. J Inherit Metab Dis 1994;17:487-499.
2. Danpure CJ: Advances in the enzymology and molecular genetics of primary hyperoxaluria type 1: prospects for gene therapy. Nephrol Dial Transplant 1995;10(suppl 8):24-29.
3. Danpure CJ, et al: Targeting of alanine: glyoxylate aminotransferase in normal individuals and its mistargeting in patients with primary hyperoxaluria type 1. Ann NY Acad Sci 1996;804:477-490.
4. Cochat P, et al: Epidemiology of primary hyperoxaluria type 1. Societé de Nephrologie and the Société de Néphrologie Pédiatrique. Nephrol Dial Transplant 1995;10(suppl 8):3-7.
5. van Woerden CS, et al: Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome. Nephrol Dial Transplant 2003;18:273-279.
6. Zhang X, et al: Crystal structure of alanine:glyoxylate aminotransferase and the relationship between genotype and enzymatic phenotype in primary hyperoxaluria type 1. J Mol Biol 2003;331:643-652.
7. Yuen YP, et al: Novel mutations of the AGXT gene causing primary hyperoxaluria type 1. J Nephrol 2004;17:436-440.
8. Santana A, et al: Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase. Proc Natl Acad Sci USA 2003;100:7277-7282.
9. Rumsby G: Biochemical and genetic diagnosis of the primary hyperoxalurias: a review. Mol Urol 2000;4:349-354.
10. Basmaison O, et al: Identification of 5 novel mutations in the AGXT gene. Hum Mutat 2000;15:577.
11. von Schnakenburg C, et al: Genetic analysis: a diagnostic tool for primary hyperoxaluria type 1. Pediatr Nephrol 2003;18:482-483.
12. Danpure CJ: The molecular basis of alanine: glyoxylate aminotransferase mistargeting: the most common single cause of primary hyperoxaluria type 1. J Nephrol 1998;11(suppl 1):8-12.
13. Gibbs D, Watts R: The idientification of the enzymes that catalyse the oxidation of glyoxylate to oxalate in toe 100,000 g supernatant fraction of human hyperoxaluric and control liver and heart tissue. Clin Sci 1973;44:227-241.
14. Scheinman JI: Primary hyperoxaluria: therapeutic strategies for the 90's. Kidney Int 1991;40:389-399.
15. Leumann E, et al: Efficacy of oral citrate administration in primary hyperoxaluria. Nephrol Dial Transplant 1995;10(suppl 8):14-16.
16. Leumann E, Matasovic A, Niederwieser A: Pyridoxine in primary hyperoxaluria type I. Lancet 1986;ii:699.
17. Milliner DS, et al: Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med 1994;331:1553-1558.
18. Milliner DS, Wilson DM, Smith LH: Clinical expression and long-term outcomes of primary hyperoxaluria types 1 and 2. J Nephrol 1998;11(suppl 1):56-59.
19. Pirulli D, Marangella M, Amoroso A: Primary hyperoxaluria: genotype-phenotype correlation. J Nephrol 2003;16:297-309.
20. Shapiro R, et al: Primary hyperoxaluria type 1: improved outcome with timely liver transplantation. A single-center report of 36 children. Transplantation 2001;72:428-432.
21. Yamauchi T, et al: Oxalate removal by daily dialysis in a patient with primary hyperoxaluria type 1. Nephrol Dial Transplant 2001;16:2407-2411.
22. Hoppe B, et al: Oxalate elimination via hemodialysis or peritoneal dialysis in children with chronic renal failure. Pediatr Nephrol 1996;10:488-492.
23. Scheinman JI: Recent data on results of isolated kidney or combined kidney/liver transplantation in the USA for primary hyperoxaluria. J Nephrol 1998:11(suppl 1):42-45.
24. Monico CG, Milliner DS: Combined liver-kidney and kidney-alone transplantation in primary hyperoxaluria. Liver Transpl 2001;7:954-963.
25. Broyer M, et al: Kidney transplantation in primary oxalosis: data from the EDTA registry. Nephrol Dial Transplant 1990;5:332-336.
26. Hoppe B, Langman CB: A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr Nephrol 2003;18:986-991.
27. Watts RW, et al: Primary hyperoxaluria (type I): attempted treatment by combined hepatic and renal transplantation. Q J Med 1985;57:697-703.
28. Donckier V, et al: Domino hepatic transplantation using the liver from a patient with primary hyperoxaluria. Transplantation 2001;71:1346-1348.
29. Watts RW, et al: Successful treatment of primary hyperoxaluria type I by combined hepatic and renal transplantation. Lancet 1987;ii: 474-475.
30. Jamieson NV: The results of combined liver/kidney transplantation for primary hyperoxaluria (PH1) 1984-1997. The European PH1 transplant registry report. European PH1 Transplantation Study Group. J Nephrol 1998;11(suppl 1):36-41.
31. Gagnadoux MF, et al: Long term results of liver-kidney transplantation in children with primary hyperoxaluria. Pediatr Nephrol 2001;16:946-950.
32. Ellis SR, et al: Combined liver-kidney transplantation for primary hyperoxaluria type 1 in young children. Nephrol Dial Transplant 2001;16:348-354.
33. Millan MT, et al: One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience. Transplantation 2003;76:1458-1463.
34. Saborio P, Scheinman JI: Transplantation for primary hyperoxaluria in the United States. Kidney Int 1999;56:1094-1100.
35. Cibrik DM, et al: Renal allograft survival in patients with oxalosis. Transplantation 2002;74:707-710.
36. Latta K, et al: Selection of transplantation procedures and perioperative management in primary hyperoxaluria type 1. Nephrol Dial Transplant 1995;10(suppl 8):53-57.
37. Astarcioglu I, et al: Primary hyperoxaluria: simultaneous combined liver and kidney transplantation from a living related donor. Liver Transpl 2003;9:433-436.
38. Gruessner RW: Preemptive liver transplantation from a living related donor for primary hyperoxaluria type I. N Engl J Med 1998;338:1924.
39. Kemper MJ, et al: Preemptive liver transplantation in primary hyperoxaluria type 1: timing and preliminary results. J Nephrol 1998;11 (suppl 1):46-48.
40. Nolkemper D, et al: Long-term results of preemptive liver transplantation in primary hyperoxaluria type 1. Pediatr Transplant 2000;4:177-1781.
41. Leumann E, Hoppe B: Pre-emptive liver transplantation in primary hyperoxaluria type 1: a controversial issue. Pediatr Transplant 2000;4:161-164.
42. Rodby RA, Tyszka TS, Williams JW: Reversal of cardiac dysfunction secondary to type 1 primary hyperoxaluria after combined liver-kidney transplantation. Am J Med 1991;90:498-504.
43. Toussaint C, et al: Radiological and histological improvement of oxalate osteopathy after combined liver-kidney transplantation in primary hyperoxaluria type 1. Am J Kidney Dis 1993;21:54-63.
44. Detry O, et al: Reversal of oxalosis cardiomyopathy after combined liver and kidney transplantation. Transpl Int 2002;15:50-52.